The WHO held a press conference about the situation Thursday. Here are five key takeaways: At present no one who is ill is ...

Fabricated” citations that do not reference real academic papers are spreading in the literature, polluting the public record ...

Most researchers conduct their more disruptive work early in their careers, but as they age, they tend to abandon that ...

Sanofi asked the FDA to pull teplizumab out of a speedy review voucher program after a political appointee disagreed with ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

Scientists are worried that hantaviruses haven’t been as well studied as they ought to be, but not that the MV Hondius cruise ...

The Italian firm Angelini Pharma is buying Catalyst Pharmaceuticals, the maker of rare disease drugs, for $4.1 billion.

Also, FDA leadership is facing fresh accusations of political interference in drug reviews, AI oncology startups are trying to make cancer care virtual, and scientists are opening up an entirely new ...

Health and Human Services Secretary Robert F. Kennedy Jr. fired around 3,500 workers from the Food and Drug Administration ...

The retirement of Luis Rodríguez, who has been part of the Vessel Sanitation Program since 2010 and served as its chief since ...

A next-gen Duchenne therapy from Entrada Therapeutics fell short in an early study, as a number of companies race to make ...

In this week's Biotech Scorecard newsletter, Adam Feuerstein takes on the company touting gold microdust suspended in water ...